Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANDA Application Backlogs, Submission Bubbles Plague User Fee Rollout

Executive Summary

FDA says in its first GDUFA performance report to Congress that it met all statutory requirements in fiscal year 2013, but while the agency worked on several FY 2013 applications, it did not approve an original ANDA submitted that year.

Advertisement

Related Content

FDA Generics Office Hopes To Clear Unmeasured ANDAs
Backlog Backfire: FDA Sees Increase In Pending Generic Applications At Deadline

Topics

Advertisement
UsernamePublicRestriction

Register

PS055930

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel